12.97
Precedente Chiudi:
$12.51
Aprire:
$12.65
Volume 24 ore:
1.27M
Relative Volume:
0.87
Capitalizzazione di mercato:
$690.35M
Reddito:
$312.78M
Utile/perdita netta:
$-143.56M
Rapporto P/E:
-4.8216
EPS:
-2.69
Flusso di cassa netto:
$1.22M
1 W Prestazione:
+9.54%
1M Prestazione:
-0.38%
6M Prestazione:
-41.81%
1 anno Prestazione:
-58.11%
Caredx Inc Stock (CDNA) Company Profile
Nome
Caredx Inc
Settore
Industria
Telefono
415-287-2300
Indirizzo
8000 MARINA BLVD, BRISBANE, CA
Confronta CDNA con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
CDNA
Caredx Inc
|
12.97 | 630.74M | 312.78M | -143.56M | 1.22M | -2.69 |
![]()
TMO
Thermo Fisher Scientific Inc
|
499.99 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
211.80 | 149.66B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
645.55 | 51.03B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
121.63 | 33.56B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
191.15 | 32.73B | 15.70B | 1.24B | 2.01B | 6.91 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-01-15 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
2024-08-28 | Iniziato | Wells Fargo | Underweight |
2024-08-19 | Aggiornamento | BTIG Research | Neutral → Buy |
2024-05-13 | Downgrade | Raymond James | Outperform → Mkt Perform |
2024-05-01 | Aggiornamento | Craig Hallum | Hold → Buy |
2023-11-09 | Aggiornamento | Stephens | Equal-Weight → Overweight |
2023-08-15 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2023-05-11 | Downgrade | BTIG Research | Buy → Neutral |
2023-03-07 | Downgrade | Stephens | Overweight → Equal-Weight |
2023-03-03 | Downgrade | Craig Hallum | Buy → Hold |
2023-03-03 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
2022-04-25 | Iniziato | Stephens | Overweight |
2021-07-20 | Ripresa | BTIG Research | Buy |
2021-06-03 | Iniziato | Goldman | Buy |
2021-02-26 | Downgrade | H.C. Wainwright | Buy → Neutral |
2020-10-30 | Reiterato | H.C. Wainwright | Buy |
2020-10-08 | Reiterato | H.C. Wainwright | Buy |
2020-10-02 | Reiterato | H.C. Wainwright | Buy |
2020-08-05 | Reiterato | H.C. Wainwright | Buy |
2020-06-26 | Iniziato | BTIG Research | Buy |
2020-06-19 | Reiterato | H.C. Wainwright | Buy |
2019-10-01 | Ripresa | Craig Hallum | Buy |
2019-05-09 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
2019-02-15 | Iniziato | Jefferies | Buy |
2018-10-23 | Ripresa | Raymond James | Strong Buy |
2018-09-18 | Reiterato | H.C. Wainwright | Neutral |
2017-11-27 | Iniziato | H.C. Wainwright | Buy |
2016-06-14 | Reiterato | Mizuho | Buy |
2015-09-29 | Downgrade | Raymond James | Outperform → Mkt Perform |
2015-09-25 | Iniziato | Craig Hallum | Buy |
2015-03-18 | Reiterato | Mizuho | Buy |
Mostra tutto
Caredx Inc Borsa (CDNA) Ultime notizie
The Play On CareDx (NASDAQ:CDNA) - Seeking Alpha
CareDx Inc stock momentum explainedOil Prices & Weekly Top Gainers Trade List - Newser
CareDx price target lowered to $22 from $26 at BTIG - MSN
Detecting support and resistance levels for CareDx Inc2025 Bull vs Bear & Safe Swing Trade Setups - Newser
Is a relief rally coming for CareDx Inc holdersPortfolio Risk Report & Free Fast Gain Swing Trade Alerts - Newser
How to escape a deep drawdown in CareDx IncTrade Risk Assessment & Daily Entry Point Trade Alerts - Newser
Real time alert setup for CareDx Inc performanceTrade Risk Summary & Free High Return Stock Watch Alerts - Newser
Historical volatility pattern of CareDx Inc visualized2025 Dividend Review & Daily Chart Pattern Signal Reports - Newser
How hedge fund analytics apply to CareDx Inc stockPrice Action & Daily Stock Momentum Reports - Newser
Relative strength of CareDx Inc in sector analysisWeekly Profit Analysis & High Conviction Buy Zone Alerts - Newser
Is CareDx Inc building a consolidation baseTrend Reversal & Reliable Trade Execution Plans - Newser
Forecasting CareDx Inc price range with options dataJuly 2025 Decliners & Real-Time Market Sentiment Alerts - Newser
Technical analysis overview for CareDx Inc stockJuly 2025 Recap & Technical Buy Zone Confirmations - Newser
Smart tools for monitoring CareDx Inc’s price actionQuarterly Portfolio Report & Consistent Growth Stock Picks - Newser
Should you wait for a breakout in CareDx Inc2025 Key Lessons & Weekly Top Stock Performers List - Newser
Visual analytics tools that track CareDx Inc performance2025 Sector Review & Growth Focused Stock Pick Reports - Newser
CareDx Inc’s Beta Climbs After Market VolatilityJuly 2025 Chart Watch & Short-Term High Return Strategies - metal.it
Predicting CareDx Inc trend using moving averages2025 Key Lessons & Safe Capital Allocation Plans - Newser
CareDx Inc stock trend forecastMarket Performance Summary & Reliable Volume Spike Trade Alerts - Newser
CareDx's (NASDAQ:CDNA) Earnings Aren't As Good As They Appear - Yahoo Finance
US Bancorp DE Purchases 1,235 Shares of CareDx, Inc. (NASDAQ:CDNA) - Defense World
CareDx stock price target lowered to $22 at BTIG on Medicare reimbursement concerns - Investing.com Australia
CareDx's Q2 2025 Earnings: Unpacking Contradictions in EPIC Launch, Legal Settlements, and Volume Growth - AInvest
CareDx (CDNA): Analyst Lowers Price Target, Maintains Rating | C - GuruFocus
Wells Fargo & Company Lowers CareDx (NASDAQ:CDNA) Price Target to $14.00 - Defense World
CareDx (CDNA) Price Target Cut to $14.00, Analyst Maintains 'Equal-Weight' Rating - AInvest
CareDx Reports Strong Growth in Testing Services - MSN
CareDx Inc. Reports Strong Growth Amid Challenges - The Globe and Mail
CareDx, Inc (NASDAQ:CDNA) Q2 2025 Earnings Call Transcript - Insider Monkey
CDNA’s Market Fluctuations: Is Now the Right Time to Invest? - investchronicle.com
CareDx: Wells Fargo downgrades to Equal-Weight, PT to $14 from $19. - AInvest
CareDx Q2 2025 slides: 14% revenue growth despite analyst miss, EBITDA surges - Investing.com
How CareDx Inc stock performs during market volatility300% Return Stock Forecast - classian.co.kr
CareDx (NASDAQ:CDNA) Shares Gap Down After Earnings Miss - Defense World
CareDx Publishes KOAR Study In American Journal of Transplantation, Showcasing AlloSure Dd-cfDNA For Enhanced Kidney Rejection Detection And Biopsy Guidance - 富途牛牛
CareDx (CDNA) Lags Q2 Earnings and Revenue Estimates - MSN
CareDx Appoints New CFO Amid Financial Growth - The Globe and Mail
CareDx secretary Novack sells $34,380 in shares - Investing.com
CareDx secretary Novack sells $34,380 in shares By Investing.com - Investing.com Canada
CareDx Faces Financial Challenges Amid Mixed Signals and Policy Uncertainties - TipRanks
CareDx 2025 Q2 Earnings EPS Beats Expectations, Net Loss Widens - AInvest
CareDx shares fall 10.61% intraday after CFO changes and earnings guidance narrowing. - AInvest
CareDx narrows 2025 revenue guidance to $367M-$373M as kidney surveillance protocols expand - MSN
CareDx Names Nathan Smith as Chief Financial Officer - MarketScreener
CareDx (CDNA) EPS Beats Sales Gain 14% - sharewise.com
Earnings call transcript: CareDx Q2 2025 misses revenue forecasts By Investing.com - Investing.com Canada
Earnings call transcript: CareDx Q2 2025 misses revenue forecasts - Investing.com
CareDx Q2 2025 Earnings: EPS of -$0.10 Meets Estimates, Revenue of $90.5 Million Slightly Misses Expectations - AInvest
CareDx Publishes Landmark KOAR Study on AlloSure Efficacy in Kidney Transplant Surveillance in American Journal of Transplantation. - AInvest
CareDx: Q2 Earnings Snapshot - Greenwich Time
CareDx Announces Appointment of Nathan Smith as Chief Financial Officer - BioSpace
Caredx Inc Azioni (CDNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):